Biochemistry & Nutrition

Permanent URI for this community

http://localhost:4000/handle/123456789/51

Browse

Browsing Biochemistry & Nutrition by Subject "amino acid"

Now showing 1 - 3 of 3
  • Item
    Chemical composition and nutritional value of anchovy (stolephorus commersonii) caught from Kerala coast, India
    (Pelagia Research Library, 2013) Sankar, T.V.; Anandan, R.; Mathew, S.; Asha, K.K.; Lakshmanan, P.T.; Varkey, J.; Aneesh, P.A.
    Proximate composition, amino acid profile, fatty acid composition and mineral status of Commerson’s anchovy (Stolephorus commersonii) in three different size groups (3-5g,6-10g,25-30g)were studied. Moisture content was high in big size group and low in small size group. Fat content was found to be high in small size group and low in big size group showing an inverse relation between moisture content and fat content. It was observed that the protein content was high in medium sized fish. The essential amino acid content was significantly higher in small(3- 5g)and medium sized fish compared to larger fish. The polyunsaturated fatty acid content was higher in small sized anchovies compared to other groups. The docosahexaenoic acid (DHA) content was five times higher than the eicosapentaenoic acid (EPA) content in all the fishes irrespective of size. The higher content of EPA produces antithrombotic anti-inflammatory effects and help in calcium metabolism. The mineral content was found higher in small sized fishes. Anchovy can be a cheap and ideal dietary supplement for children and elderly.
  • Item
    Comparative study of the nutrient content of fish and shell fish
    (Society of Fishery Technologists (India), 1981) Mukundan, M.K.; Radhakrishnan, A.G.; James, M.A.; Nair, M.R.
    The amino acid, mineral and proximate composition of mullet (Mugil oeur ), mackerel (Rastrelliger kanagurta ), crab (Scylla serrata ) and prawn (Penaeus indius ) are reported. The data are used for comparing the nutritional quality of the fish and shell fish. Further, the amino acid composition is screened for their adequacy to meet the FAO/WHO recommended pattern of essential amino acids.
  • Item
    Effect of taurine on glucose metabolism in experimentally-induced fulminant hepatic failure in rats
    (Society of Fisheries Technologists (India), 2010) Asha, K.K.; Devadasan, K.
    Fulminant hepatic failure (FHF) is a devastating illness that has a high mortality rate and affects patients with previously healthy livers (Moreno- Gonzalez etal. 1995). Although an uncommon disorder, it is usually fatal and is defined as the occurrence of encephalopathy in a previously healthy person, within eight weeks from onset of severe liver disease. Although the etiology of FHF remains unclear, viral hepatitis and drug-induced liver injury account for the majority of causes. FHF caused by viral hepatitis is a national health problem in the developing countries. Hepatitis E causes large-scale epidemics of hepatitis in the Indian subcontinent, involving hundreds of thousands of cases with high mortality (Acharya et at., 2000; Khan et al., 2006) Clinical features of FHF can be divided into two broad groups: (i) manifestations of acute hepatic injury, namely, jaundice, shrunken liver, high liver enzymes, deficiency of clotting factors and other synthetic functions of the liver; and (U) multi-organ failure and a wide range of metabolic disturbances. All patients should be managed in an intensive care setting pending transfer to a liver transplantation center. Several issues namely selection of patients, appropriate timing of the transplant, the difficulty of making donor liver available within a short period of time, and postoperative course of these sick patients, and the fact that liver transplant should take place before severe irreversible brain damage has made transplantation for FHF a very challenging field (Turchetti, 2003). Despite this complexity, impressive recent progress has been achieved in advancing our understanding and appreciation of the cellular processes and mechanistic bases underlying fulminate hepatic failure. Effective clinical application of hepatoprotective and cytotrophic drugs may offer valuable time to provide a donor liver, or alternatively, to allow the native liver to regenerate.